Risk Management for Avoidance of Drug Shortages

About the Author

Christine M. V. Moore, PhD
Executive Director, Quality Systems & Compliance
Organon LLC
Dr. Christine Moore is a founding member of Organon where she leads Global External Advocacy and Standards, providing oversight for implementation of new GMP-related policy...
Jean-François Duliere
Regulatory Advisor
ISPE
Jean Francois Duliere is a Pharmacist by education. Jean Francois started his professional life 20 years in pharmaceutical industry Quality Control, Production in various positions...
John G. Groskoph
Executive Director, Global CMC
Pfizer
John Groskoph leads the New Products CMC function at Pfizer and has over 20 years of pharmaceutical industry experience. John has worked in a variety...
Diane L. Hustead
Executive Director, Regulatory Affairs
Merck & Co., Inc.
Diane Hustead is an advanced regulatory affairs expert and drug shortage industry leader with enthusiasm and dedication to pharmaceutical manufacturing excellence. With a diverse career...
Christopher John Potter, PhD
CMC Pharmaceutical Consultant
Chris Potter graduated from the University of Exeter with a degree in chemistry and completed a PhD at Imperial College London University in organic chemistry...